TGA Approval

OMTRALO 49/51 sacubitril/valsartan (combined as a sodium salt hydrate complex) 48.6/51.4 mg film-coated tablet blister pack (475686)

ARTG ID

475686

ARTG Name

OMTRALO 49/51 sacubitril/valsartan (combined as a sodium salt hydrate complex) 48.6/51.4 mg film-coated tablet blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

March 31, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Novartis Pharmaceuticals Australia Pty Ltd

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

Active Ingredients

Ingredient Name

sacubitril

Ingredient Name

valsartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

OMTRALO 49/51 sacubitril/valsartan (combined as a sodium salt hydrate complex) 48.6/51.4 mg film-coated tablet blister pack (475686) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

OMTRALO 49/51 sacubitril/valsartan (combined as a sodium salt hydrate complex) 48.6/51.4 mg film-coated tablet blister pack (475686)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal